Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysmKirsten Riches‐Suman, Karen E. Porter|Journal of Translational Medicine|2013Cited by 71
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous veinRomana Mughal, Karen E. Porter|Diabetologia|2010Cited by 64
Functional angiotensin‐converting enzyme 2 is expressed in human cardiac myofibroblastsJodie L. Guy, Karen E. Porter|Experimental Physiology|2008Cited by 41
Role of MicroRNA-145 in DNA Damage Signalling and Senescence in Vascular Smooth Muscle Cells of Type 2 Diabetic PatientsKaren E. Hemmings, Karen E. Porter|Cells|2021Cited by 15
Aberrant Phenotype in Human Endothelial Cells of Diabetic Origin: Implications for Saphenous Vein Graft Failure?A Roberts, Karen E. Porter|Journal of Diabetes Research|2015Cited by 11